Findings

What do systematic reviews say?

4,703 questions · 15,007 findings · 1,416 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,881 · 19.2%GRADE not reported 1,551 · 10.3%Very low 3,111 · 20.7%Low 3,881 · 25.9%Moderate 2,669 · 17.8%High 914 · 6.1%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Alglucosidase alfa vs placebo

QoL (PCS in SF‐36 (measured on a scale from 0 to 100)) · 90 people with LOPD

1 finding from 1 review

Enzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 90 participants
Low

Alglucosidase alfa vs placebo

Treatment‐related AEs: total treatment‐emergent adverse events potentially related to treatment · 90 people with LOPD

Alglucosidase alfa showed no clear difference in treatment‐related AEs compared with placebo (low certainty).

1 finding from 1 review

Enzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes only
RR 0.94 [0.64, 1.39]
1 study · 90 participants
Low

Alglucosidase alfa plus clenbuterol vs alglucosidase alfa plus placebo

Change from baseline in 6MWT (metres) · 13 people with LOPD

1 finding from 1 review

Enzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 10 participants
Very low

Alglucosidase alfa plus clenbuterol vs alglucosidase alfa plus placebo

FVC (% predicted) Change from baseline · 13 people with LOPD

1 finding from 1 review

Enzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Very low

Aromatherapy vs placebo or usual care

Tiredness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Exhaustion · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Asthenia · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupressure vs placebo or control

Fatigue · people receiving dialysis

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 459 participants
Low

Acupressure vs placebo or control

Weakness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupressure vs placebo or control

Energy · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupressure vs placebo or control

Tiredness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupressure vs placebo or control

Exhaustion · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupressure vs placebo or control

Asthenia · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Fatigue · people receiving dialysis

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 542 participants
Low

Aromatherapy vs placebo or usual care

Weakness · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aromatherapy vs placebo or usual care

Energy · people receiving dialysis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin vs placebo

UGIH‐related mortality · people with acute UGIH

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 255 participants
Very low

Erythromycin plus nasogastric tube lavage vs no intervention/placebo plus nasogastric tube lavage

All‐cause mortality · people with acute UGIH

It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 238 participants
Very low

Erythromycin plus nasogastric tube lavage vs no intervention/placebo plus nasogastric tube lavage

Visualisation of gastric mucosa · people with acute UGIH

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 170 participants
Very low

Erythromycin plus nasogastric tube lavage vs no intervention/placebo plus nasogastric tube lavage

NSAEs · people with acute UGIH

It is very uncertain whether erythromycin plus nasogastric tube lavage changes NSAEs compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
RD 0
6 studies · 408 participants
Very low